Study unlocks mystery of child leukemia relapse
By Will Dunham
WASHINGTON (Reuters) - A certain gene abnormality raises the chance of relapse for children with the most common form of childhood cancer, a discovery that could change the way doctors treat them, U.S. researchers said on Wednesday.
Children with acute lymphoblastic leukemia, or ALL, who have abnormalities in a gene called IKZF1 are three times as likely to have a relapse than those who do not, the researchers wrote in the New England Journal of Medicine.
The findings could lead to a genetic test to identify children at high risk of relapse, according to Dr. James Downing of St. Jude Children’s Research Hospital in Memphis, Tennessee, one of the researchers.
Those children might then get more aggressive treatment than usual, such as intensified chemotherapy, in a bid to ward off a relapse, Downing said.
“These are children. Once cured, they’re going to live a full and long life,” Downing said in a telephone interview. “If they don’t need to be treated aggressively, don’t treat them aggressively. But you want to cure them.”
The gene produces a protein that regulates the activity of many other genes and plays an important role in the development of lymphocytes. These white blood cells are the ones that undergo changes to give rise to pediatric ALL.
The cure rate with existing treatment for children with ALL is about 80 percent. About a quarter suffer a relapse, and 30 percent of those children only survive up to five years.
Doctors have been unable to determine which children are more likely to relapse. If they could predict that, those children might receive more intense treatment.
Doctors hesitate to routinely use intensified chemotherapy because of its toxicity, but knowing a child has this genetic abnormality might outweigh the risk, Downing said.
The researchers looked at genetic information from 221 child patients, comparing their cancer cells to their own normal cells to spot any changes. They confirmed the findings in a second group of 258 children with ALL.
About three-quarters of those with abnormalities relating to the gene relapsed, Downing said.
The study identified a series of abnormalities in the gene that increased relapse risk. For example, some children had no working copies of the gene, some had one working copy and in some cases an abnormal copy interfered with a good one.
--------------------------------------------------------------------------------------------Related Posts:
By Will Dunham WASHINGTON (Reuters) - Distinctive genetic changes occur in the cancer cells that trigger relapse in patients with the most common type of childhood cancer, according to a study that may offer new hope for beating the disease. Writing in the journal Science on Thursday, the scientists described key genetic differences in cancer cells of
Full Post: Scientists track genetic changes in leukemia
--------------------------------------------------------------------------------------------
By Julie Steenhuysen CHICAGO (Reuters) - A single gene appears to play a crucial role in deadly breast cancers, increasing the chances the cancer will spread and making it resistant to chemotherapy, U.S. researchers said on Monday. They found people with aggressive breast cancers have abnormal genetic alterations in a gene called MTDH, and drugs that block
Full Post: Scientists find a gene that makes cancer spread
--------------------------------------------------------------------------------------------
By Will Dunham WASHINGTON (Reuters) - A rare genetic abnormality found in people in an insular Amish community protects them from heart disease, a discovery that could lead to new drugs to prevent heart ailments, U.S. researchers said on Thursday. About 5 percent of Old Order Amish people in Pennsylvania’s Lancaster County have only one working copy
Full Post: Amish gene trait may inspire heart protection
--------------------------------------------------------------------------------------------
LONDON (Reuters) - The first baby girl in Britain to have been screened before conception for a genetic form of breast cancer has been born, doctors said on Friday. While a first in Britain, the strategy has been used elsewhere across the world to screen for the cancer-related BRCA1 gene variant, and the technique has also
Full Post: UK’s first breast cancer gene screen baby born
--------------------------------------------------------------------------------------------
CHICAGO (Reuters) - Genes that increase the risk of heart disease in the general population carry an even greater risk of heart trouble in diabetics, U.S. researchers said on Tuesday. The findings may help better identify which diabetics are at risk for heart disease and could lead to new treatments, they said. “Coronary artery disease is one
Full Post: Genes that raise heart risks amplified in diabetics